• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真性红细胞增多症中JAK2V617F会损害钙网蛋白对人类应激性红细胞生成的调控。

The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera.

作者信息

Falchi Mario, Varricchio Lilian, Martelli Fabrizio, Marra Manuela, Picconi Orietta, Tafuri Agostino, Girelli Gabriella, Uversky Vladimir N, Migliaccio Anna Rita

机构信息

National AIDS Center, Istituto Superiore Sanita, Rome, Italy.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Exp Hematol. 2017 Jun;50:53-76. doi: 10.1016/j.exphem.2017.02.001. Epub 2017 Feb 21.

DOI:10.1016/j.exphem.2017.02.001
PMID:28232234
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5779852/
Abstract

Calreticulin (CALR) is a Ca-binding protein that shuttles among cellular compartments with proteins bound to its N/P domains. The knowledge that activation of the human erythropoietin receptor induces Ca fluxes prompted us to investigate the role of CALR in human erythropoiesis. As shown by Western blot analysis, erythroblasts generated in vitro from normal sources and JAK2V617F polycythemia vera (PV) patients expressed robust levels of CALR. However, Ca regulated CALR conformation only in normal cells. Normal erythroblasts expressed mostly the N-terminal domain of CALR (N-CALR) on their cell surface (as shown by flow cytometry) and C-terminal domain (C-CALR) in their cytoplasm (as shown by confocal microscopy) and expression of both epitopes decreased with maturation. In the proerythroblast (proEry) cytoplasm, C-CALR was associated with the glucocorticoid receptor (GR), which initiated the stress response. In these cells, Ca deprivation and inhibition of nuclear export increased GR nuclear localization while decreasing cytoplasmic detection of C-CALR and C-CALR/GR association and proliferation in response to the GR agonist dexamethasone (Dex). C-CALR/GR association and Dex responsiveness were instead increased by Ca and erythropoietin. In contrast, JAK2V617F proErys expressed normal cell-surface levels of N-CALR but barely detectable cytoplasmic levels of C-CALR. These cells contained GR mainly in the nucleus and were Dex unresponsive. Ruxolitinib rescued cytoplasmic detection of C-CALR, C-CALR/GR association, and Dex responsiveness in JAK2V617F proErys and its effects were antagonized by nuclear export and Ca flux inhibitors. These results indicates that Ca-induced conformational changes of CALR regulate nuclear export of GR in normal erythroblasts and that JAK2V617F deregulates this function in PV.

摘要

钙网蛋白(CALR)是一种钙结合蛋白,它与结合在其N/P结构域的蛋白质在细胞区室之间穿梭。人类促红细胞生成素受体的激活会诱导钙通量这一认识促使我们研究CALR在人类红细胞生成中的作用。如蛋白质印迹分析所示,从正常来源和JAK2V617F真性红细胞增多症(PV)患者体外生成的成红细胞表达高水平的CALR。然而,钙仅在正常细胞中调节CALR构象。正常成红细胞在其细胞表面主要表达CALR的N端结构域(N-CALR)(流式细胞术显示),在其细胞质中表达C端结构域(C-CALR)(共聚焦显微镜显示),并且随着成熟,这两个表位的表达均降低。在早幼红细胞(proEry)细胞质中,C-CALR与糖皮质激素受体(GR)相关联,后者启动应激反应。在这些细胞中,钙剥夺和核输出抑制增加了GR的核定位,同时减少了C-CALR和C-CALR/GR关联的细胞质检测以及对GR激动剂地塞米松(Dex)的增殖反应。相反,钙和促红细胞生成素增加了C-CALR/GR关联和对Dex的反应性。相比之下,JAK2V617F proErys表达正常细胞表面水平的N-CALR,但几乎检测不到细胞质水平的C-CALR。这些细胞中的GR主要存在于细胞核中,对Dex无反应。鲁索替尼挽救了JAK2V617F proErys中C-CALR的细胞质检测、C-CALR/GR关联和对Dex的反应性,其作用被核输出和钙通量抑制剂拮抗。这些结果表明,钙诱导的CALR构象变化调节正常成红细胞中GR的核输出,并且JAK2V617F在PV中使该功能失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/ed42475d0e7c/nihms933900f11a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/278fabb224cc/nihms933900f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/af335e493fbc/nihms933900f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/834bc5739a49/nihms933900f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/172275a04254/nihms933900f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/95d89bd2cdcf/nihms933900f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/c299b16383a2/nihms933900f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/2804c55b7526/nihms933900f7a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/6c7a91a08618/nihms933900f8a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/f0c8ed17f93a/nihms933900f9a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/6e90d4e33191/nihms933900f10a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/ed42475d0e7c/nihms933900f11a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/278fabb224cc/nihms933900f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/af335e493fbc/nihms933900f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/834bc5739a49/nihms933900f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/172275a04254/nihms933900f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/95d89bd2cdcf/nihms933900f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/c299b16383a2/nihms933900f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/2804c55b7526/nihms933900f7a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/6c7a91a08618/nihms933900f8a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/f0c8ed17f93a/nihms933900f9a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/6e90d4e33191/nihms933900f10a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e9/5779852/ed42475d0e7c/nihms933900f11a.jpg

相似文献

1
The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera.真性红细胞增多症中JAK2V617F会损害钙网蛋白对人类应激性红细胞生成的调控。
Exp Hematol. 2017 Jun;50:53-76. doi: 10.1016/j.exphem.2017.02.001. Epub 2017 Feb 21.
2
Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations.携带CALR、JAK2V617F、JAK2Ex12del和MPLW515L/K突变的日本真性红细胞增多症和原发性血小板增多症患者的临床特征。
Leuk Res. 2016 Jan;40:68-76. doi: 10.1016/j.leukres.2015.11.002. Epub 2015 Nov 10.
3
Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F.促炎细胞因子肝细胞生长因子和白细胞介素-11 在真性红细胞增多症中过度表达,并独立于 JAK2V617F 促进克隆性红细胞的生长。
Oncogene. 2011 Feb 24;30(8):990-1001. doi: 10.1038/onc.2010.479. Epub 2010 Nov 1.
4
Altered Ca Homeostasis in Red Blood Cells of Polycythemia Vera Patients Following Disturbed Organelle Sorting during Terminal Erythropoiesis.真性红细胞增多症患者终末红细胞生成过程中细胞器分拣紊乱导致红细胞内钙稳态改变。
Cells. 2021 Dec 24;11(1):49. doi: 10.3390/cells11010049.
5
Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera.正常供者和真性红细胞增多症患者体外扩增红细胞的转录组和磷酸化蛋白质组分析。
Am J Hematol. 2013 Sep;88(9):723-9. doi: 10.1002/ajh.23487. Epub 2013 Jul 3.
6
Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.真性红细胞增多症的转录谱分析确定了依赖和不依赖 JAK2V617F 作用的基因表达模式。
Clin Cancer Res. 2010 Sep 1;16(17):4339-52. doi: 10.1158/1078-0432.CCR-10-1092. Epub 2010 Jul 2.
7
Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the mutation.在携带该突变的真性红细胞增多症患者的红细胞中,钙网蛋白表达增强。
Haematologica. 2017 Jul;102(7):e241-e244. doi: 10.3324/haematol.2016.161604. Epub 2017 Apr 6.
8
Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms.JAK2V617F和CALR突变的骨髓增殖性肿瘤中CD34+造血祖细胞的特征分析
Leuk Res. 2016 Sep;48:11-5. doi: 10.1016/j.leukres.2016.06.009. Epub 2016 Jun 29.
9
The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients.糖皮质激素受体的显性负效β异构体仅在从真性红细胞增多症患者扩增的红细胞中表达。
Blood. 2011 Jul 14;118(2):425-36. doi: 10.1182/blood-2010-07-296921. Epub 2011 Feb 25.
10
Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.转化生长因子-β(TGF-β)抑制作为骨髓纤维化治疗靶点的临床前理论依据。
Exp Hematol. 2016 Dec;44(12):1138-1155.e4. doi: 10.1016/j.exphem.2016.08.007. Epub 2016 Aug 31.

引用本文的文献

1
Structural and Dynamic Differences between Calreticulin Mutants Associated with Essential Thrombocythemia.与原发性血小板增多症相关的钙网织蛋白突变体的结构和动态差异。
Biomolecules. 2023 Mar 10;13(3):509. doi: 10.3390/biom13030509.
2
Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential.血液癌症中失调的钙信号传导:潜在机制与治疗潜力
Front Oncol. 2022 Oct 18;12:1010506. doi: 10.3389/fonc.2022.1010506. eCollection 2022.
3
Altered Ca Homeostasis in Red Blood Cells of Polycythemia Vera Patients Following Disturbed Organelle Sorting during Terminal Erythropoiesis.

本文引用的文献

1
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.CALR 突变型骨髓增殖性肿瘤中钙网织蛋白突变激活血小板生成素受体。
Blood. 2016 Mar 10;127(10):1307-16. doi: 10.1182/blood-2015-09-671172. Epub 2016 Jan 27.
2
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.骨髓增殖性肿瘤相关钙网蛋白突变体对血小板生成素受体的激活作用。
Blood. 2016 Mar 10;127(10):1325-35. doi: 10.1182/blood-2015-11-681932. Epub 2015 Dec 14.
3
CALR mutations screening in wild type JAK2(V617F) and MPL(W515K/L) Brazilian myeloproliferative neoplasm patients.
真性红细胞增多症患者终末红细胞生成过程中细胞器分拣紊乱导致红细胞内钙稳态改变。
Cells. 2021 Dec 24;11(1):49. doi: 10.3390/cells11010049.
4
Evolution and new frontiers of histology in bio-medical research.组织学在生物医学研究中的演进和新前沿。
Microsc Res Tech. 2021 Feb;84(2):217-237. doi: 10.1002/jemt.23579. Epub 2020 Sep 11.
5
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia.真性红细胞增多症中血管性血友病因子水平升高及与原发性血小板增多症的表型差异。
Res Pract Thromb Haemost. 2020 Feb 28;4(3):413-421. doi: 10.1002/rth2.12315. eCollection 2020 Mar.
6
Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function.钙网蛋白:钙网蛋白内在无序的性质对其功能研究提出的挑战
Front Cell Dev Biol. 2017 Nov 23;5:96. doi: 10.3389/fcell.2017.00096. eCollection 2017.
7
Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus.原发性血小板增多症中的钙网蛋白:使巨核细胞核应激
Front Oncol. 2017 May 22;7:103. doi: 10.3389/fonc.2017.00103. eCollection 2017.
野生型JAK2(V617F)和MPL(W515K/L)巴西骨髓增殖性肿瘤患者的CALR突变筛查
Blood Cells Mol Dis. 2015 Oct;55(3):236-40. doi: 10.1016/j.bcmd.2015.07.005. Epub 2015 Jul 9.
4
Emerging EPO and EPO receptor regulators and signal transducers.新型促红细胞生成素及其受体调节剂和信号转导分子
Blood. 2015 Jun 4;125(23):3536-41. doi: 10.1182/blood-2014-11-575357. Epub 2015 Apr 17.
5
Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion.直接靶向巨噬细胞的地塞米松可诱导促进红系细胞扩增的巨噬细胞微环境。
Haematologica. 2015 Feb;100(2):178-87. doi: 10.3324/haematol.2014.114405. Epub 2014 Dec 22.
6
Calreticulin: roles in cell-surface protein expression.钙网蛋白:在细胞表面蛋白表达中的作用
Membranes (Basel). 2014 Sep 16;4(3):630-41. doi: 10.3390/membranes4030630.
7
JAK inhibitor in CALR-mutant myelofibrosis.JAK抑制剂在CALR突变型骨髓纤维化中的应用
N Engl J Med. 2014 Mar 20;370(12):1168-9. doi: 10.1056/NEJMc1400499.
8
Mutated calreticulin retains structurally disordered C terminus that cannot bind Ca(2+): some mechanistic and therapeutic implications.突变的钙网蛋白保留了无法结合Ca(2+)的结构紊乱的C末端:一些机制和治疗意义。
Blood Cancer J. 2014 Feb 21;4(2):e185. doi: 10.1038/bcj.2014.7.
9
Primitive and definitive erythropoiesis in mammals.哺乳动物中的原始红细胞生成和确定性红细胞生成。
Front Physiol. 2014 Jan 28;5:3. doi: 10.3389/fphys.2014.00003. eCollection 2014.
10
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.伴有未突变 JAK2 的骨髓增殖性肿瘤中的体细胞 CALR 突变。
N Engl J Med. 2013 Dec 19;369(25):2391-2405. doi: 10.1056/NEJMoa1312542. Epub 2013 Dec 10.